Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs PlexusDx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and PlexusDx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 112 · Grade C

PlexusDx

Visit PlexusDx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make PlexusDx a bad call — it's best for readers comparing monthly and annual medication plans who understand that optional genetic insights are not a prescription or an outcome guarantee. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
69
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
74
Track Record
88
68
CoreAge RxBrief Score 94 · 71PlexusDx

Price, coverage & the tracker

CoreAge RxPlexusDx
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$149/mo monthly option

Compounded semaglutide. Annual plan: $1,188 upfront ($99/mo equivalent); optional genetic testing extra.

Full price details

$149/month compounded semaglutide; annual plan $1,188 upfront ($99/month equivalent); optional genetic testing extra

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$189/mo monthly option

Compounded tirzepatide. Annual plan: $1,548 upfront ($129/mo equivalent); optional genetic testing extra.

Full price details

$189/month compounded tirzepatide according to current FAQ; annual plan $1,548 upfront ($129/month equivalent); optional genetic testing extra

CoverageUS only; restrictions by state, confirmed at intakeProvider and pharmacy eligibility vary by state; terms exclude Medicaid enrollees even when paying cash
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

PlexusDx: Monthly plans are $149 semaglutide and $189 tirzepatide; annual totals are $1,188/$1,548 upfront. Genetic testing is optional and prepaid plans renew automatically.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.